Basic Information
| LncRNA/CircRNA Name | NORAD |
| Synonyms | NA |
| Region | GRCh38_20:36045622-36050960 |
| Ensemble | ENSG00000260032 |
| Refseq | NR_027451 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Western blot |
| Sample | breast cancer tissues,cell lines( MCF-7 , MDA-MB-231, MCF10A) |
| Expression Pattern | up-regulated |
| Function Description | Upregulation of lnc-NORAD in breast cancer cell lines and tumor tissues |
| Pubmed ID | 30930692 |
| Year | 2019 |
| Title | High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-? pathway. |
External Links
| Links for NORAD | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |